ribavirin has been researched along with Critical Illness in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Abdulmomen, A; Al Harthy, A; Al Khatib, K; Al Mekhlafi, GA; Al Qasim, E; Al-Aithan, AM; Al-Dawood, A; Al-Hameed, F; Al-Omari, A; Al-Raddadi, R; Almotairi, A; Alraddadi, B; Arabi, YM; Balkhy, HH; Fowler, R; Gramish, JA; Hayden, FG; Jose, J; Kharaba, A; Mady, A; Maghrabi, K; Mandourah, Y; Merson, L; Qushmaq, I; Ragab, A; Shalhoub, S; Sindi, AA; Solaiman, O | 1 |
Abravanel, F; Belliere, J; Cintas, P; Cointault, O; Faguer, S; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Martinez, S; Nogier, MB | 1 |
Choi, S; Kim, JY; Kim, MC; Kim, SH; Kwon, JS; Lee, KH | 1 |
Al-Tawfiq, JA; Dib, J; Memish, ZA; Momattin, H | 1 |
Gomersall, CD; Leung, CH | 1 |
Choi, SH; Chon, GR; Han, MS; Hong, SB; Huh, JW; Kim, HR; Kim, MJ; Kim, SH; Kim, WY; Kim, YS; Ko, YG; Lee, KH; Ryu, YJ; Young Suh, G | 1 |
6 other study(ies) available for ribavirin and Critical Illness
Article | Year |
---|---|
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study.
Topics: Aged; Antiviral Agents; Coronavirus Infections; Critical Illness; Female; Humans; Intensive Care Units; Interferon alpha-2; Male; Middle Aged; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; Retrospective Studies; Ribavirin; RNA, Viral; Saudi Arabia; Treatment Outcome | 2020 |
Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient.
Topics: Antiviral Agents; Blood Transfusion; Critical Illness; Diagnostic Errors; Fatal Outcome; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Multiple Organ Failure; Muscular Diseases; Polyneuropathies; Polyradiculoneuropathy; Postoperative Period; Ribavirin; RNA, Viral | 2017 |
Case Report: Use of Plasma Exchange Followed by Convalescent Plasma Therapy in a Critically Ill Patient with Severe Fever and Thrombocytopenia Syndrome-Associated Encephalopathy: Cytokine/Chemokine Concentrations, Viral Loads, and Antibody Responses.
Topics: Aged; Antibodies, Viral; Antiviral Agents; Brain Diseases; Bunyaviridae Infections; Chemokine CXCL10; Convalescence; Critical Illness; Humans; Interferon-alpha; Male; Phlebovirus; Plasma Exchange; Republic of Korea; Ribavirin; Therapies, Investigational; Tissue Donors; Treatment Outcome; Viral Load | 2018 |
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus; Coronavirus Infections; Critical Illness; Diabetes Mellitus; Female; Humans; Hypertension; Imipenem; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult | 2014 |
Middle East respiratory syndrome.
Topics: Acute Kidney Injury; Algorithms; Antiviral Agents; Coronavirus Infections; Critical Care; Critical Illness; Humans; Interferons; L-Lactate Dehydrogenase; Lymphopenia; Protective Clothing; Respiration, Artificial; Ribavirin; Thrombocytopenia | 2014 |
Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Cohort Studies; Critical Illness; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Korea; Male; Middle Aged; Oseltamivir; Pandemics; Respiration, Artificial; Retrospective Studies; Ribavirin; Treatment Outcome | 2011 |